A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom

Background: Vulvovaginal atrophy (VVA) is characterized by vaginal/vulvar dryness, irritation, dyspareunia, or dysuria. The objective of this study was to examine the efficacy and safety of a very low-dose estradiol vaginal cream (0.003%) applied twice per week in postmenopausal women with VVA-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Archer, David F., Kimble, Thomas D., Lin, F.D. Yuhua, Battucci, Simona, Sniukiene, Vilma, Liu, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865261/
https://www.ncbi.nlm.nih.gov/pubmed/29193980
http://dx.doi.org/10.1089/jwh.2017.6515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865261/
https://www.ncbi.nlm.nih.gov/pubmed/29193980
http://dx.doi.org/10.1089/jwh.2017.6515

Ejemplares similares